Selenomethionine

CHEMBL113178 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

196.1 g/mol

LogP

—

Phase

4

Selenomethionine is an organic selenium compound, the primary dietary form of selenium in plants and a precursor to selenocysteine-containing selenoproteins with antioxidant functions. It is used as a selenium supplement and has been investigated for chemopreventive properties in age-related macular degeneration, asthma, and various cancers. As a methionine analog, it is incorporated into proteins in place of methionine and serves as a selenium reservoir in the body.

الوزن الجزيئي

196,1200 g/mol

TPSA

63,30 Å²

المجالات العلاجية

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Age-Related Macular Degeneration Non-Small Cell Lung Cancer Asthma Chronic Obstructive Pulmonary Disease Non-Alcoholic Fatty Liver Disease Lymphoma Breast Cancer HIV/AIDS Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

C[Se]CC[C@H](N)C(=O)O

InChI

InChI=1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1

Molecular Formula

C5H11NO2Se

HBD / HBA

2 / 3

الروابط القابلة للدوران

4

الذرات الثقيلة

9

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

Selenomethionine is an organic selenium compound, the primary dietary form of selenium in plants and a precursor to selenocysteine-containing selenoproteins with antioxidant functions. It is used as a selenium supplement and has been investigated for chemopreventive properties in age-related macular degeneration, asthma, and various cancers. As a methionine analog, it is incorporated into proteins in place of methionine and serves as a selenium reservoir in the body.

Yes, Selenomethionine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL113178. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 15103. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Selenomethionine على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C5H11NO2Se
المرادفات: 4

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.